BIOLASE, Inc. (BIOL) - רווח נקי למניה (EPS TTM)
Waterlase system shipments generate moderate revenue as BIOLASE, Inc. (BIOL) strives for profitability. The current rolling annual EPS helps track profit dynamics amid market volatility, where the value of -20.52 expresses the metric level. BIOLASE, Inc. (BIOL) dominates the dental laser segment, replacing traditional drills. Global sales of gum therapy equipment minimize operational risks.
BIOL (BIOLASE Inc.): פילוחים אנליטיים ודוחות לפי אינדיקטורים
A qualitative asset valuation requires an analysis of the business's actual earnings per common share. This indicator measures the rolling annual net income, excluding the impact of one-time adjustments and accounting noise. The trend of fundamental earnings per share TTM allows for the identification of hidden anomalies in the issuer's financial stability. For BIOLASE, Inc. (BIOL), this chart is critically important due to chronic losses and capital dilution via secondary offerings. Such volatility in the metric signals delisting risks.
